Vaccines
New Research on Vaccines from University of Milan Summarized
Published in Medical Letter on the CDC and FDA, August 14th, 2011
2011 AUG 14 -- "This study was designed to evaluate the immunogenicity, safety, and tolerability of a monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in children aged 6 to 23 months who had different gestational ages (GAs) at birth. The study involved 105 children: 35 preterm subjects with a GA of < 32 weeks; 35 preterm subjects with a GA of 32 to 36 weeks; and 35 term subjects with a GA of 37 to 42 weeks," researchers in Milan, Italy report.
"Each child received 2 intramuscular vaccine doses (Focetria [Novartis, Siena, Italy]): dose 1 at enrollment and dose 2 after 4 weeks (28 +/- 2 days). Serum samples for antibody measurements were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- CDC and FDA
Research from C.C. Ginocchio and Co-Researchers Provides New Data on CDC and FDA - Vaccines
Investigators at Kaiser Permanente Vaccine Study Center Release New Data on Vaccines - Vaccines
Investigators at University Hospital Center Release New Data on Vaccines - U.S. Food and Drug Administration
Lilly Launches Physician Payment Registry - Blood Coagulation Factors
New Blood Coagulation Factors Study Findings Have Been Reported from R. Akiyama et al - Influenza Vaccines
New Findings from Baskent University in the Area of Influenza Vaccines Described - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
